• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自SUP-T1淋巴母细胞的人血管活性肠肽受体的分子克隆与功能表征

Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts.

作者信息

Svoboda M, Tastenoy M, Van Rampelbergh J, Goossens J F, De Neef P, Waelbroeck M, Robberecht P

机构信息

Department of Biochemistry and Nutrition, Medical School, Université Libre de Bruxelles, Belgium.

出版信息

Biochem Biophys Res Commun. 1994 Dec 30;205(3):1617-24. doi: 10.1006/bbrc.1994.2852.

DOI:10.1006/bbrc.1994.2852
PMID:7811244
Abstract

We have cloned and sequenced a cDNA isolated from a human SUP-T1 lymphoblast cell line library. It encoded a 457 amino acids protein having 87% identity with the rat PACAP type II, VIP2 receptor. Chinese hamster ovary (CHO) cells stably transfected with cloned cDNA expressed a specific binding of 125I[Acetyl-His1]PACAP-27. This binding was inhibited by GTP, and by the peptides helodermin, VIP, PACAP-27 and PACAP-38 that also stimulated adenylate cyclase activity. The order of potency was PACAP-38 > VIP > or = helodermin > or = PACAP-27. Comparison of the results in two cell lines expressing different receptor densities suggested that helodermin and PACAP-38 had a higher intrinsic activity than VIP and PACAP-27.

摘要

我们已经克隆并测序了从人SUP-T1淋巴母细胞系文库中分离出的一个cDNA。它编码一种由457个氨基酸组成的蛋白质,与大鼠PACAP II型VIP2受体有87%的同源性。用克隆的cDNA稳定转染的中国仓鼠卵巢(CHO)细胞表达了125I[乙酰基 - 组氨酸1]PACAP - 27的特异性结合。这种结合被GTP以及也能刺激腺苷酸环化酶活性的肽类海洛德明、VIP、PACAP - 27和PACAP - 38所抑制。其效力顺序为PACAP - 38 > VIP ≥ 海洛德明 ≥ PACAP - 27。在表达不同受体密度的两种细胞系中的结果比较表明,海洛德明和PACAP - 38比VIP和PACAP - 27具有更高的内在活性。

相似文献

1
Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts.来自SUP-T1淋巴母细胞的人血管活性肠肽受体的分子克隆与功能表征
Biochem Biophys Res Commun. 1994 Dec 30;205(3):1617-24. doi: 10.1006/bbrc.1994.2852.
2
Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.血管活性肠肽(VIP)、蛙皮素和垂体腺苷酸环化酶激活肽(PACAP)的类似物可区分大鼠和人类的VIP1和VIP2受体。
Ann N Y Acad Sci. 1998 Dec 11;865:247-52. doi: 10.1111/j.1749-6632.1998.tb11184.x.
3
A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.克隆的蛙血管活性肠肽/垂体腺苷酸环化酶激活肽受体具有哺乳动物中VPAC1和VPAC2受体的药理学及组织分布特征。
Endocrinology. 1999 Mar;140(3):1285-93. doi: 10.1210/endo.140.3.6576.
4
The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.垂体腺苷酸环化酶激活多肽(PACAP)通过人SUP-T1淋巴细胞膜中偏好蛙皮素的血管活性肠肽(VIP)受体激活腺苷酸环化酶。
Biochim Biophys Acta. 1991 Jul 22;1066(2):245-51. doi: 10.1016/0005-2736(91)90193-c.
5
Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.垂体腺苷酸环化酶激活多肽I和II受体、血管活性肠肽1以及嵌合氨基末端垂体腺苷酸环化酶激活多肽/血管活性肠肽1受体的特性:多种受体状态的证据
Mol Pharmacol. 1996 Dec;50(6):1596-604.
6
Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.人良性增生前列腺中血管活性肠肽/垂体腺苷酸环化酶激活肽受体的特征分析
Endocrinology. 1996 Jul;137(7):2815-22. doi: 10.1210/endo.137.7.8770902.
7
The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass.长效血管活性肠肽激动剂RO 25 - 1553对VIP2受体亚类具有高度选择性。
Peptides. 1997;18(3):403-8. doi: 10.1016/s0196-9781(96)00322-1.
8
Structural and functional identification of the pituitary adenylate cyclase-activating polypeptide receptor VPAC2 from the frog Rana tigrina rugulosa.虎纹蛙垂体腺苷酸环化酶激活多肽受体VPAC2的结构与功能鉴定
J Mol Endocrinol. 2001 Oct;27(2):229-38. doi: 10.1677/jme.0.0270229.
9
Cloning and expression of a complementary DNA encoding the bovine receptor for pituitary adenylate cyclase-activating polypeptide (PACAP).编码牛垂体腺苷酸环化酶激活多肽(PACAP)受体的互补DNA的克隆与表达。
Biochim Biophys Acta. 1994 Aug 2;1218(3):297-307. doi: 10.1016/0167-4781(94)90181-3.
10
Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor.编码人垂体腺苷酸环化酶激活多肽受体的cDNA的分子克隆与功能表达
Biochem Biophys Res Commun. 1993 Nov 15;196(3):1511-21. doi: 10.1006/bbrc.1993.2423.

引用本文的文献

1
A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases.VIP 轴在炎症和自身免疫性疾病中的应用的临床方法。
Int J Mol Sci. 2019 Dec 20;21(1):65. doi: 10.3390/ijms21010065.
2
Discovery of PACAP and its receptors in the brain.脑内 PACAP 及其受体的发现。
J Headache Pain. 2018 Apr 4;19(1):28. doi: 10.1186/s10194-018-0855-1.
3
Molecular cloning and characterization of two pig vasoactive intestinal polypeptide receptors (VPAC1-R and VPAC2-R).猪两种血管活性肠肽受体(VPAC1-R 和 VPAC2-R)的克隆与特性分析。
DNA Cell Biol. 2014 Apr;33(4):259-70. doi: 10.1089/dna.2013.2235. Epub 2014 Feb 12.
4
VPAC1 receptor expression in peripheral blood mononuclear cells in a human endotoxemia model.在人类内毒素血症模型中,外周血单个核细胞中 VPAC1 受体的表达。
J Transl Med. 2013 May 7;11:117. doi: 10.1186/1479-5876-11-117.
5
Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).神经肽血管活性肠肽(VIP)对肠道二肽转运的抑制作用是通过人肠上皮样细胞系(Caco-2)中的VPAC1受体产生的一种抗吸收效应。
Br J Pharmacol. 2003 Feb;138(4):564-73. doi: 10.1038/sj.bjp.0705049.
6
Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor.血管活性肠肽的苏氨酸11残基与VPAC2受体第一细胞外环中的酪氨酸184之间存在直接相互作用的证据。
Biochem J. 2003 Mar 15;370(Pt 3):1003-9. doi: 10.1042/BJ20020811.
7
Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation.人类血管活性肠肽受体第一个跨膜螺旋中的两个酪氨酸残基在维持活性构象方面发挥作用。
Br J Pharmacol. 2002 Aug;136(7):1042-8. doi: 10.1038/sj.bjp.0704802.
8
Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.人血管活性肠肽受体亚型VPAC(2)的突变分析:第二个跨膜螺旋中碱性残基的作用
Br J Pharmacol. 2001 Aug;133(8):1249-54. doi: 10.1038/sj.bjp.0704195.
9
Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.一种新型VPAC(1)选择性激动剂的表征以及参与羧基末端肽识别的受体结构域的鉴定。
Br J Pharmacol. 2000 Jun;130(4):819-26. doi: 10.1038/sj.bjp.0703384.
10
Pituitary adenylate cyclase-activating polypeptide inhibits transforming growth factor-beta1-induced apoptosis in a human pituitary adenoma cell line.垂体腺苷酸环化酶激活多肽抑制人垂体腺瘤细胞系中转化生长因子-β1诱导的细胞凋亡。
Am J Pathol. 1999 Dec;155(6):1893-900. doi: 10.1016/s0002-9440(10)65509-5.